CLINICAL AND EPIDEMIOLOGICAL ASSESSMENT OF THE PREVALENCE OF LIVER FIBROSIS ASSOCIATED WITH METABOLICALLY RELATED NECROINFLAMMATORY CHANGES IN PATIENTS WITH CHRONIC HEPATITIS.

Kurbonov Khayitjon Shavkat o`g`li

Authors

Kurbonov Khayitjon Shavkat o`g`li Asia International University Bukhara,Uzbekistan

Keywords:

Viral Hepatitis, metabolic disturbances, BMI, liver function tests

Abstract

Background
The coexistence of metabolic disorders with Chronic Hepatitis B has become an important clinical issue in hepatology. Increasing evidence suggests that metabolic abnormalities, including Hepatic steatosis and insulin resistance, may influence the progression of chronic viral liver disease and contribute to necro-inflammatory activity and the development of Liver Fibrosis. However, the extent to which viral or host-related metabolic factors contribute to hepatic steatosis in patients with chronic hepatitis B remains insufficiently clarified.

Objective
Aim of this study was to investigate the prevalence of metabolic disturbances and their association with necro-inflammatory changes and liver fibrosis in patients with viral hepatitis.

Methods
This study included 74 patients diagnosed with viral hepatitis. Clinical evaluation and laboratory investigations identified metabolic disturbances in 24 patients. Group 1 included patients with metabolic disturbances (n=24) and group 2 included those without metabolic disturbances (n=50). The groups were compared in terms of age, body mass index (BMI), viral load, and other biochemical parameters. Patients in group 1 were further categorized according to the severity of metabolic abnormalities.

Results

In group 1 (n=24), mean age, BMI, cholesterol, and HOMA-IR values were significantly higher compared with group 2 (n=50). There were no significant differences between the groups in viral load, HBeAg positivity, or other laboratory parameters. Logistic regression analysis identified HOMA-IR as the only independent predictor of metabolic disturbances in patients with viral hepatitis.

Conclusion

Metabolic disturbances in patients with viral hepatitis were primarily associated with host metabolic factors rather than viral characteristics. Early identification and management of these metabolic abnormalities may help prevent progression of liver injury.

References

Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97–107. doi: 10.1046/j.1365-2893.2003.00487.x. [DOI] [PubMed] [Google Scholar]

Schiff E, Sorell M, Maddrey W. Disease of the Liver. 6th ed. Philadelphia: Lippincott-Williams and Wilkins; 1999. [Google Scholar]

Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140(1):124–131. doi: 10.1053/j.gastro.2010.09.038. [DOI] [PubMed] [Google Scholar]

Hui JM, Kench JG, Chitturi S, Sud A, Farrell GC, Byth K, et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology. 2003;38(2):420–427. doi: 10.1053/jhep.2003.50320. [DOI] [PubMed] [Google Scholar]

Lonardo A, Loria P, Adinolfi LE, Carulli N, Ruggiero G. Hepatitis C and steatosis: a reappraisal. J Viral Hepat. 2006;13(2):73–80. doi: 10.1111/j.1365-2893.2005.00669.x. [DOI] [PubMed] [Google Scholar]

Yoon EJ, Hu KQ. Hepatitis C virus (HCV) infection and hepatic steatosis. Int J Med Sci. 2006;3(2):53–56. doi: 10.7150/ijms.3.53. [DOI] [PMC free article] [PubMed] [Google Scholar]

Wong VW, Wong GL, Yu J, Choi PC, Chan AW, Chan HY, et al. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Am J Gastroenterol. 2010;105(1):132–138. doi: 10.1038/ajg.2009.560. [DOI] [PubMed] [Google Scholar]

Peng D, Han Y, Ding H, Wei L. Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors. J Gastroenterol Hepatol. 2008;23(7 Pt 1):1082–1088. doi: 10.1111/j.1440-1746.2008.05478.x. [DOI] [PubMed] [Google Scholar]

Altlparmak E, Koklu S, Yalinkilic M, Yuksel O, Cicek B, Kayacetin E, et al. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol. 2005;11(20):3056–3059. doi: 10.3748/wjg.v11.i20.3056. [DOI] [PMC free article] [PubMed] [Google Scholar]

Thomopoulos KC, Arvaniti V, Tsamantas AC, Dimitropoulou D, Gogos CA, Siagris D, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol. 2006;18(3):233–237. doi: 10.1097/00042737-200603000-00002. [DOI] [PubMed] [Google Scholar]

Bondini S, Kallman J, Wheeler A, Prakash S, Gramlich T, Jondle DM, et al. Impact of non-alcoholic fatty liver disease on chronic hepatitis B. Liver Int. 2007;27(5):607–611. doi: 10.1111/j.1478-3231.2007.01482.x. [DOI] [PubMed] [Google Scholar]

Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1(5):431–435. doi: 10.1002/hep.1840010511. [DOI] [PubMed] [Google Scholar]

Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94(9):2467–2474. doi: 10.1111/j.1572-0241.1999.01377.x. [DOI] [PubMed] [Google Scholar]